公司资料
ABVC BioPharma, Inc. 股价、新闻与催化剂
- 股票代码:
- ABVC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States and trades on NASDAQ, placing it in the small-cap biotech category
股票表现
0.85 USD (-5.56%)
收盘价
最后更新: 2026年8月17日
32.5M USD
市值
股价为何变动
As of Aug 17, 2026, ABVC closed down 5.56% at $0.8499. No new same-company headline was identified in the current news window.
公司概览
业务概览
ABVC BioPharma is a small biotechnology company with programs spanning areas such as oncology, ophthalmology, and central nervous system health. Its profile is that of a micro-cap development company trying to create value through a mix of early-stage assets and licensing opportunities.
所在地与行业分类
ABVC is headquartered in the United States and trades on NASDAQ, placing it in the small-cap biotech category. It is a development-stage name with limited commercial scale.
商业模式特征
The business model depends on early clinical development, licensing, strategic partnerships, and financing discipline. Investors usually watch pipeline announcements, trial progress, and whether the company can sustain enough runway to advance its programs.
生物医药行业定位
ABVC sits in the speculative micro-cap side of biotech. The stock is usually driven by announcements, capital structure, and the company's ability to maintain credibility across multiple early programs.
未来催化剂
- ABVC BioPharma’s catalysts are its partnered clinical assets and any update that clarifies whether the company can still convert the pipeline into a viable path. The market will care about concrete progress rather than broad promises.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。